While the rapidly evolving healthcare investment landscape in Malaysia and South East Asia offers abundant opportunities for investment in healthcare groups, hospitals and specialist medical centers, nevertheless sustained growth for the mid to long term future will require the synergistic combination of established healthcare players, brands and astute private investor groups, to explore new boundaries in healthcare operations, to include clinical research, bio and medical technology innovations.